Goblet cells are abundant throughout the gastrointestinal tract and secrete products which form a continuous viscoelastic coat on the mucosal surface. Trefoil peptides, a family of structurally distinct small peptides specifically expressed in a regionalized fashion at all levels of the gastrointestinal tract, have been identified as a previously unappreciated major product of goblet cell populations. Trefoil factors are critical constituents at the mucosal-lumenal interface contributing to preservation of mucosal integrity, and protecting against a variety of noxious insults in in vivo model systems. Furthermore, preliminary studies suggest that expression of the representative trefoil ITF (Intestinal Trefoil Factor) is directly dependent on transcriptional factors which are associated with commitment of a pluripotent intestinal epithelial stem cell to the goblet cell lineage. However, insight into the molecular basis of trefoil peptide expression in a cell- and tissue-specific manner and the dimensions of their functional activity in sustaining epithelial integrity remains incomplete. The main goals of the studies in this proposal are the delineation of the mechanisms through which these abundant peptides sustain mucosal integrity, and the elucidation of the molecular regulation of the genes encoding the trefoil in order to define both the molecular basis of goblet cell specific gene expression and commitment to goblet cell differentiation. Two major specific aims are planned. (I) Determination of function and mechanisms of action of trefoil peptides. Preliminary studies have suggested that trefoil peptides are mediated through receptors and utilize distinct intracellular signalling pathways. The trefoil peptide receptor will be cloned and its mechanism of action characterized, while the intracellular processes that mediate its mitogenic effects will be defined. (II) Determination of the molecular basis of goblet-cell specific expression of ITF. Studies have identified a novel cis regulatory element in the ITF promoter which confers goblet cell expression of reporter genes in vivo. A nuclear factor which binds this element will be characterized through transient transfection and transgenic approaches. Collectively, these studies should provide insights into the trefoil family of proteins a newly recognized dimension of mucosal biology as well as the molecular basis of intestinal and goblet cell function, most importantly including the molecular basis of stem cell commitment to the goblet cell lineage. These insights promise to field new perspective on mechanisms of mucosal destruction, repair and function in inflammatory bowel disease and other forms of injury in the gastrointestinal tract.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK046906-09
Application #
6545257
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Hamilton, Frank A
Project Start
1994-05-01
Project End
2007-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
9
Fiscal Year
2002
Total Cost
$378,608
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Paulsen, Friedrich P; Woon, Chee-Wai; Varoga, Deike et al. (2008) Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds. J Biol Chem 283:13418-27
Kalabis, Jiri; Rosenberg, Ian; Podolsky, Daniel K (2006) Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium. J Biol Chem 281:6434-41
Beck, P L; Wong, J F; Li, Y et al. (2004) Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 126:796-808
Fernandez-Estivariz, Concepcion; Gu, Li H; Gu, Liang et al. (2003) Trefoil peptide expression and goblet cell number in rat intestine: effects of KGF and fasting-refeeding. Am J Physiol Regul Integr Comp Physiol 284:R564-73
Iwakiri, D; Podolsky, D K (2001) A silencer inhibitor confers specific expression of intestinal trefoil factor in gobletlike cell lines. Am J Physiol Gastrointest Liver Physiol 280:G1114-23
Andoh, A; Kinoshita, K; Rosenberg, I et al. (2001) Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells. J Immunol 167:3887-93
Iwakiri, D; Podolsky, D K (2001) Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor. Gastroenterology 120:1372-80
Taupin, D R; Kinoshita, K; Podolsky, D K (2000) Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A 97:799-804
Podolsky, D K (2000) Review article: healing after inflammatory injury--coordination of a regulatory peptide network. Aliment Pharmacol Ther 14 Suppl 1:87-93
Kinoshita, K; Taupin, D R; Itoh, H et al. (2000) Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20:4680-90

Showing the most recent 10 out of 24 publications